Madison, WI 的 黑色素瘤 臨床試驗
15 項針對 黑色素瘤 的研究正在 Madison（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- William S Middleton VA Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
招募中1/2 期
- UW Hospital and Clinics, Madison
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
招募中3 期
- University of Wisconsin Carbone Cancer Center, Madison
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
招募中2 期
- Local Institution - 0134, Madison
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
招募中2 期
- University of Wisconsin Carbone Cancer Center, Madison
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
招募中1/2 期
- University of Wisconsin-Madison Carbone Cancer Center, Madison
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
招募中1/2 期
- The Board of Regents of the University of Wisconsin, Madison
Project: Every Child for Younger Patients With Cancer
招募中觀察性研究
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
招募中1/2 期
- University of Wisconsin- Madison, Madison
Neoadjuvant Darovasertib in Primary Uveal Melanoma
招募中3 期
- University of Wisconsin Health, Madison
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
招募中2/3 期
- University Of Wisconsin Carbone Cancer Center - University Hospital, Madison
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中觀察性研究
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients
招募中觀察性研究
- University of Wisconsin Hospitals and Clinics (UWHC), Madison
In Vivo Liquid Biopsy of Melanoma (Cytophone)
招募中歡迎健康志工
- SSM Health Dean Medical Group Specialty Services, Madison
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
招募中
- University of Winsconsin Carbone Cancer Center-Eastpark medical Center, Madison
- University of Wisconsin Carbone Cancer Center, Madison
其他城市的 黑色素瘤 試驗
- Houston, TX59 項研究
- New York City, NY38 項研究
- Los Angeles, CA34 項研究
- Nashville, TN33 項研究
- Pittsburgh, PA31 項研究
- Boston, MA26 項研究
- Philadelphia, PA23 項研究
- San Francisco, CA22 項研究
- Columbus, OH21 項研究
- Durham, NC21 項研究
- Atlanta, GA21 項研究
- Salt Lake City, UT21 項研究
Madison 的其他研究
- 前列腺癌29 項研究
- 大腸直腸癌23 項研究
- 乳癌22 項研究
- 轉移性癌症21 項研究
- 急性髓系白血病16 項研究
- 非小細胞肺癌16 項研究
- 癌症（所有類型）14 項研究
- 卵巢癌13 項研究
- 胃癌11 項研究
- 胰臟癌10 項研究
- 肺癌10 項研究
- 多發性骨髓瘤9 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。